WHO Warns Ebola Vaccine for Rare Species Could Take Nine Months
Health officials report rising deaths in Central Africa as the rare Bundibugyo species spreads without an available vaccine.
Primary source: BBC World News. Full source links and update notes are below.
Fast summary
Start here
- The World Health Organization (WHO) estimated a nine-month development timeline for vaccines targeting the rare Bundibugyo Ebola species.
- Health officials have recorded 600 suspected cases and 139 suspected deaths, including confirmed cases in both DR Congo and Uganda.
- The WHO has declared a public health emergency of international concern but clarified that the situation does not yet constitute a pandemic.
What happened
The World Health Organization (WHO) announced that a vaccine for the Bundibugyo species of Ebola currently spreading in Central Africa is likely nine months away. WHO chief Dr. Tedros Adhanom Ghebreyesus reported 600 suspected cases and 139 suspected deaths, noting that figures are expected to rise as detection capabilities improve across the region.
What's new in this update
WHO advisor Dr. Vasee Moorthy confirmed that while two candidate vaccines are in development, neither has yet undergone clinical trials. On Tuesday, the WHO emergency committee agreed the situation is a public health emergency of international concern but is not at a pandemic level. The organization assesses the global risk as low, while the risk at national and regional levels remains high.
Key details
There are 51 confirmed cases in the Democratic Republic of Congo, primarily located in the eastern provinces of Ituri and North Kivu. Two cases were confirmed in the Ugandan capital of Kampala, both involving individuals who traveled from DR Congo. Local healthcare facilities are reportedly overwhelmed, with some medical staff continuing to work without adequate personal protective equipment despite the arrival of new supplies.
Background and context
The Bundibugyo species is one of four known to cause disease in humans but has not been seen for more than a decade. It previously caused outbreaks in 2007 and 2012, killing about a third of those infected. Unlike the more common Zaire species, which DR Congo has experience managing with existing vaccines, the rarity of Bundibugyo presents significant challenges for immediate medical intervention.
What to watch next
Health investigators are currently tracing the transmission path to determine how long the virus has been spreading undetected. The primary focus for the WHO and local authorities is curbing transmission through contact tracing and improved hygiene practices. The outbreak's origin is currently traced back to a nurse who died in April in the provincial capital of Bunia.
Why it matters
This outbreak involves a rare species of Ebola not seen in a decade, meaning existing vaccines are ineffective and containment relies solely on public health measures.
Read next
Follow this story through the topic hub, more world coverage, and the latest updates.
Weekly briefing
Get the week's key developments in one concise email.
Get a fast catch-up on the biggest stories, the context behind them, and the links worth your time.
Cadence
Weekly, for a quick catch-up
Coverage
AI, business, world, security, sports
Format
Clear takeaways and useful context
Request the briefing
Leave your email to open a prepared request and get on the list for the weekly briefing.
Author
See who assembled this story and follow more of their work.
Sources and methodology